Chronic inflammation of the gastric mucosa with regression in dogs (Chronic atrophic gastritis)

Research into chronic Vomiting in dogs is shifting from isolated organ findings toward systemic explanations. The focus is on three axes: microbiome – bile acids – motility. Metagenomics and metabolomics are intended to clarify how dysbiosis and altered bile acid pools contribute to mucosal irritation, Nausea, and motility-related fasting vomiting. At the same time, neurogastroenterology is advancing: sensory pathways, central vomiting centers, and peripheral mediators (e.g., serotonin, ghrelin, motilin) are being investigated as therapeutic targets. Imaging is evolving into functional diagnosis: high-resolution ultrasound kinematics, gastric emptying tests, and—in individual cases—capsule endoscopy provide dynamic parameters rather than morphology alone. Biomarker panels (Inflammatory conditions, permeability, epithelial regeneration) are intended to make invasive biopsies less often necessary and to indicate therapy response early. In therapy, studies link precision-medicine diets (hydrolyzed, reduced-fat, adjusted fiber/bile acid binders) with individually titrated prokinetics and antiemesis; probiotic consortia are selected rationally rather than “shotgun.” Digital symptom diaries and AI-based pattern recognition could reliably distinguish between Vomiting, regurgitation, and Cough and identify flare triggers. Finally, One Health perspectives are gaining weight: environmental factors, feed supply chains, and mycotoxin-associated inflammatory conditions are being addressed interdisciplinarily. The goal is an algorithm that predicts etiology, severity, and the optimal interventional approach early and gently.